Contents
Download PDF
pdf Download XML
403 Views
117 Downloads
Share this article
Research Article | Volume 13 Issue:1 (, 2023) | Pages 63 - 67
To Study Clinical and Socio-Demographic Profile of Oral Submucous Fibrosis
Under a Creative Commons license
Open Access
DOI : 10.5083/ejcm
Published
Jan. 9, 2023
Abstract

Background: Oral Submucosal fibrosis (OSMF) is one of the most prevalent premalignant conditions in India which is easy to diagnose but difficult to manage. At present it is considered as irreversible and incurable. Aims: Assessment of risk factors and the role of habit variables such as duration and frequency in the severity of OSMF and to ascertain the association of gender predilection for different habits and severity of OSMF. Material and Methods: Patient personal history was recorded with chewing habits, including frequency and duration of chewing. This descriptive retrospective study of 179 OSMF patients was carried out at the tertiary level hospital in the central India. The clinico-demographic data including details of habits was collected. Clinical staging was done on the basis of palpable fibrous bands. Functional staging was accomplished by measuring mouth opening.

Keywords
Recommended Articles
Research Article
Study The Effects of Dexmedetomidine on Postoperative Nausea and Vomiting. And Adverse Effects Like Bradycardia and Hypotension In Patients Undergoing Laparoscopic Surgeries
...
Published: 30/01/2025
Download PDF
Research Article
Study the hemodynamic parameters of Dexmedetomidine and Tramadol
...
Published: 30/09/2025
Download PDF
Research Article
Study the efficacy of dexmedetomidine for attenuation of hemodynamic responses in patients undergoing laparoscopic surgeries
...
Published: 30/12/2024
Download PDF
Research Article
Compare The Postoperative Analgesia and Adverse Effects of Bupivacaine in Comparison to Bupivacaine and Nalbuphine Combination During Spinal Anesthesia in Lower Abdominal Surgeries
...
Published: 30/09/2025
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.